Program Activities
New NIDA PAs and RFAs
On August 3, 2006, NIDA/CCTN released RFA-DA-07-001, Announcement of a Limited Competition of THE NATIONAL DRUG ABUSE TREATMENT CLINICAL TRIALS NETWORK (U10). This RFA announced a limited competition for competitive renewal applications from established clinical investigators to participate in the National Drug Abuse Treatment Clinical Trials Network (CTN). The competition was restricted to only those institutions that currently house an existing, active Node in the CTN. Six applications were received by the November 28, 2006 receipt date. Initial peer review is planned for February/March 2007.
On September 18, 2006, NIDA issued a Program Announcement (PA) entitled NIDA Research Education Grants in Drug Abuse and Addiction (R25) (PAR-06-550). The NIDA Research Education grant is a flexible and specialized mechanism designed to foster the development of drug addiction researchers through creative and innovative educational programs. Programs that focus on preparing researchers in cross-disciplinary integration and/or translational research of neuroscience, basic behavioral, prevention, clinical, treatment, and services research are particularly encouraged.
On December 6, 2006, NIDA issued a PA entitled Drug Abuse Prevention Intervention Research (R01) (PA-07-110). The goals of this Funding Opportunity Announcement (FOA) are to encourage investigstions of cognitive, behavioral, and social processes as they relate to: 1) the development of novel drug abuse prevention approaches; 2) the efficacy and effectiveness of newly developed and/or modified prevention programs; and 3) the processes associated with the selection, adoption, adaptation, implementation, sustainability and financing of empirically validated intervention; and 4) methodologies appropriate for studying complex aspects of prevention science.
On December 7, 2006, NIDA issued a PA entitled MDMA: Research Areas Needing More Emphasis (R01) (PA-07-112). Through this FOA, NIDA solicits grant applications from institutions/organizations that propose to focus on specific areas of MDMA research, across all research disciplines urgently needing attention.
On December 7, NIDA issued a PA entitled Health Services Research on Practice Improvement Utilizing Community Treatment Programs within the National Drug Abuse Clinical Trials Network (CTN) (R01) (PA-07-1143). This FOA solicits health services research in conjunction with NIDA's Clinical Trials Network (CTN). The CTN is a research partnership between more than 150 community treatment programs (CTPs) and drug abuse researchers in multiple sites across the country. With its extensive network of providers servicing diverse populations of drug users, the CTN provides an infrastructure for the investigation of (a) systems-level factors that facilitate practice improvement in community treatment programs and (b) new research tools to facilitate higher quality health services research on practice improvement in drug abuse treatment.
On December 7, 2006, NIDA issued a PA entitled Drug Abuse as a Cause, Correlate or Consequence of Criminal Justice Related Health Disparities Among African Americans (R01) (PA-007-114). This FOA solicits Research Project Grants (R01) applications from institutions/organizations that propose to conduct epidemiologic, prevention, treatment and services research on criminal justice related health disparities among African Americans as it relates to drug abuse and addiction.
On December 8, 2006, NIDA issued a PA entitled Inhalant Abuse: Supporting Broad-Based Research Approaches (R01) (PA-07-117). The goal of this PA is to encourage research on all aspects of inhalant abuse (i.e., epidemiology; prevention, treatment and service delivery; antecedents, consequesnces and neurobiological mechanisms).
On December 8, 2006, NIDA issued a PA entitled Prescription Drug Abuse (R01) (PA-07-123). The purpose of this FOA is to encourage research aimed at reducing prescription drug abuse while supporting appropriate medical use of therapeutic agents with abuse liability. A range of research is needed to combat prescription drug abuse--from specifying the extent and nature of the problem (including health and social consequences) and identifying their determinants, to discovering effective clinical practices that identify those at risk and designing and disseminating prevention and treatment interventions.
On December 8, 2006, NIDA issued a PA entitled Epidemiology of Drug Abuse (R01) (PA-07-118). This FOA is intended to support research projects that address (1) drug use patterns and trends within and across populations; (2) interplay of social interactions, social environment, structural context with individual behavioral characteristics and genetic vulnerability; (3) the phenotypic heterogeneity of drug abuse; (4) causal mechanisms leading to onset, maintenance, and remittance of drug abuse as well as protective mechanisms that reduce the risk of drug abuse; and (5) drug abuse over the life course, including developmental processes that influence drug use trajectories and behavioral, health and social consequences of drug abuse.
On December 14, 2006, NIDA issued a PA entitled Functional Genetics and Genomics of Drug Addiction (R01) (PA-07-166). This FOA encourages basic functional genomic research in two areas: 1) functional validation to determine which candidate genes/variants have an authentic role in addictive processes, and 2) detailed elucidation of the molecular pathways and processes modulated by candidate genes/variants, particularly for those genes with an unanticipated role in addiction. This FOA will utilize the R01 grant mechanism.
On December 14, 2006, NIDA issued a PA entitled Functional Genetics and Genomics of Drug Addiction (R03) (PA-07-168). This FOA encourages basic functional genomic research in two areas: 1) functional validation to determine which candidate genes/variants have an authentic role in addictive processes, and 2) detailed elucidation of the molecular pathways and processes modulated by candidate genes/variants, particularly for those genes with an unanticipated role in addiction. This FOA will utilize the R03 grant mechanism.
On December 14, 2006, NIDA issued a PA entitled Functional Genetics and Genomics of Drug Addiction (R21) (PA-07-167). This FOA encourages basic functional genomic research in two areas: 1) functional validation to determine which candidate genes/variants have an authentic role in addictive processes, and 2) detailed elucidation of the molecular pathways and processes modulated by candidate genes/variants, particularly for those genes with an unanticipated role in addiction. This FOA will utilize the R21 grant mechanism.
On December 21, 2006, NIDA issued a PA entitled Non-Injection Drug Abuse and HIV/AIDS (R21) (PAS-07-262). This FOA seeks to understand the contribution of non-injection drug abuse to the acquisition and/or transmission and/or disease progression of HIV/AIDS through use of the R21 mechanism to support new exploratory and developmental research projects.
On December 21, 2006, NIDA issued a PA entitled Non-Injection Drug Abuse and HIV/AIDS (R03) (PAS-07-261). This FOA seeks to understand the contribution of non-injection drug abuse to the acquisition and/or transmission and/or disease progression of HIV/AIDS through use of the NIH Small Research Grant (R03) award mechanism.
On January 5, 2007, NIDA issued a PA entitled International Research Collaboration on Drug Addiction (R01) (PA-07-275). This PA solicits collaborative research proposals on drug abuse and addiction that take advantage of special opportunities that exist outside the United States. Special opportunities include access to unusual talent, resources, populations, or environmental conditions in other countries that will speed scientific discovery. Projects must have relevance to the mission of NIDA and where feasible should address NIDA's scientific priority areas.
On January 9, 2007, NIDA issued a PA entitled Collaborative Multi-Site Research in Addiction (COMRAD) (R01) (PA-07-286). Through this PA, NIDA seeks to increase the collaboration of investigators at two or more sites in order to address critical issues in the epidemiology, services, and prevention of substance abuse and related disorders that require sample sizes or sample diversity greater than a single site can reasonably attain.
On October 17, 2006, NIDA issued an RFA entitled Development of Immunotherapeutic Products for the Treatment of Methamphetamine Addiction (U01) (RFA-DA-07-004). The objective of this solicitation is to support research in the design, synthesis, and pre-clinical evaluation of vaccines developed from methamphetamine-protein conjugates for the active immunotherapeutic treatment of methamphetamine addiction.
On October 17, 2006, NIDA issued an RFA entitled Design, Synthesis, and Preclinical Testing of Potential Treatment Agents for Drug Addiction (R01) (RFA-DA-07-006). This FOA solicits research applications from institutions/organizations that propose design, synthesis, and preclinical testing of potential treatment agents for drug addiction and/or relapse prevention.
On November 16, 2006, NIDA issued an RFA entitled Brain Imaging Drug Use Prevention Messages (R21) (RFA-DA-07-007). The purpose of this FOA is to stimulate exploratory, i.e., descriptive, hypothesis-generating, research on neurobiological responses to substance abuse prevention media messages in humans using established brain imaging methods. There is particular interest in studies across developmental stages and age groups.
On November 3, 2006, NIDA issued an RFA entitled Extinction and Pharmacotherapies for Drug Addiction (R03) (RFA-DA-07-011). The purpose of this FOA is to stimulate research on the mechanisms underlying extinction in order to guide the development of interventions for enhancing extinction of drug-seeking behavior. This FOA will utilize the R03 grant mechanism.
On November 21, 2006, NIDA issued an RFA entitled Extinction and Pharmacotherapies for Drug Addiction (R01) (RFA-DA-07-010). The purpose of this FOA is to stimulate research on the mechanisms underlying extinction in order to guide the development of interventions for enhancing extinction of drug-seeking behavior. This FOA will utilize the R01 grant mechanism.
On October 12, 2006, NIDA issued a Request for Applications entitled Mechanisms of Drug Abuse Interactions with HIV Neuropathogenesis (R21) RFA-DA-07-003 as well as a Notice of Intent to Publish an R01 Request for Applications to Accompany the Published R01 (NOT-DA-07-001). The receipt date for these applications is March 21, 2007. There is evidence that drug exposure increases the rate and/or severity of HIV-associated neurologic complications. Whether these interactions are mediated by effects on viral entry into the CNS, changes in the neural environment that affect viral replication, chronic processes that contribute to disease progression in the brain, or altered susceptibility of neural cells to damage is unknown. In order to broaden the AIDS research portfolio in both basic and clinical neuroscience, this RFA will encourage a broad range of interdisciplinary basic and/or clinical research approaches to define the basis of interaction between substances of abuse and HIV infection of the brain, including effects on neuropathogenesis and neuropathology.
On November 20, 2006, NIDA issued an RFA entitled Mechanisms of Drug Abuse Interactions with HIV Neuropathogenesis (R01) (RFA-DA-07-002). This FOA solicits research grant applications to examine the mechanisms of interaction between licit or illicit substance abuse, or medications to treat substance abuse, and events related to the etiology and pathogenesis of HIV-associated neurologic complications.
NIDA is the lead institute for a Roadmap Initiative (RFA-RM-07-004) that was released recently entitled, Facilitating Interdisciplinary Research via Methodological and Technological Innovation in the Behavioral and Social Sciences (R21). Dr. Lisa Onken is the NIDA contact for this RFA.
PAs and RFAs with Other NIH Components/Agencies
Bioengineering Research Grants (BRG) (R01) (PA-07-279)
Mechanisms, Models, Measurement and Management in Pain Research (R01) (PA-07-282)
Health Disparities in HIV/AIDS: Focus on African Americans (R21) (PA-07-289)
Health Disparities in HIV/AIDS: Focus on African Americans (R03) (PA-07-290)
Research on Social Work Practice and Concepts in Health (R01) (PA-07-292)
NIH Pathway to Independence (PI) Award (K99/R00) (PA-07-297)
Community Participation in Research (R01) (PAR-07-283)
Research on Ethical Issues in Human Subjects Research (R01) (PA-07-277)
Nanoscience and Nanotechnology in Biology and Medicine (R01) (PAR-07-270)
Nanoscience and Nanotechnology in Biology and Medicine (R21) (PAR-07-271)
Characterization, Behavior and Plasticity of Pluripotent Stem Cells (R01) (PA-07-201)
Decision Making in Health: Behavior Maintenance (R01) (PA-07-204)
Networks and Pathways Collaborative Research Projects (R01) (PA-07-266)
Collaborations with National Centers for Biomedical Computing (R01) (PAR-07-249)
Exploratory Collaborations with National Centers for Biomedical Computing (R21) (PAR-07-250)
Brain Disorders in the Developing World: Research Across the Lifespan (R01) (PAR-07-268)
Interactions Between Stem and Progenitor Cells and the Microenvironment in Vivo (R01) (PAS-07-189)
Non-Human Lentiviral Models of the Neurological Complications of AIDS (R01)
(PAS-07-191)
Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellowships (F31) to Promote Diversity in Health-Related Research (PA-07-106)
Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows (F31) (PA-07-002)
Ruth L. Kirschstein National Research Service Awards (NRSA) for Individual Postdoctoral Fellows (F32) (PA-07-107)
Research on Sleep and Sleep Disorders (PA-07-140)
Understanding Mechanisms of Health Risk Behavior Change in Children and Adolescents (R01) (PA-07-148)
The Science and Ecology of Early Development (SEED) (R01) (PA-07-149)
Health Disparities Among Minority and Underserved Women (R01) (PA-07-154)
The Effect of Racial and Ethnic/Discrimination /Bias on Healthcare Delivery (R01) (PA-07-206)
Research on Pathways Linking Environments, Behaviors and HIV/AIDS (R01)
(PAR-07-143)
Tools for Zebrafish Research (R01) (PAR-07-145)
Building Translational Research in Integrative Behavioral Science (R01) (PAR-07-155)
National Cooperative Drug Discovery Groups for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U10) (PAR-07-159)
Innovations in Biomedical Computational Science and Technology Initiative
(SBIR [R43/R44]) (PAR-07-160)
Innovations in Biomedical Computational Science and Technology Initiative
(STTR [R41/R42]) (PAR-07-161)
Research on Rural Mental Health and Drug Abuse Disorders (R01) (PA-07-103)
Co-Occurring Mental Illness, Alcohol and/or Drug Abuse & Medical Conditions (R01) (PA-07-104)
Psychopharmacology of Widely Available Psychoactive Natural Products (R01) (PA-07-108)
Cross-Disciplinary Translational Research at NIH (R01) (PA-07-109)
Behavioral & Integrative Treatment Development Program (R01) (PA-07-111)
Health Disparities in HIV/AIDS: Focus on African Americans (R01) (PA-07-116)
Health Services Research on the Prevention and Treatment of Drug and Alcohol Abuse (R01) (PA-07-119)
Complementary and Alternative Medicine for Substance Abuse and Alcohol Related Disorders (R01) (PA-07-120)
The Development of Frontal Cortex and Limbic System and Their Roles in Drug Abuse or Mental Health (R01) (PA-07-121)
Economics and Prevention and Treatment Services for Drug and Alcohol Abuse (R01) (PA-07-122)
Non-Injection Drug Abuse and HIV/AIDS (R01) (PAS-07-115)
HIV/AIDS, Severe Mental Illness and Homelessness (R01) (PA-07-090)
Social and Cultural Dimensions of Health (R01) (PA-07-045)
Research on Mind-Body Interactions and Health (R01) (PA-07-046)
Methodology and Measurement in the Behavioral and Social Sciences (R01) (PA-07-060)
Parenting Capacities and Health Outcomes in Youths and Adolescents (R01) (PA-07-061)
Mechanisms of Alcohol and Drug Induced Pancreatitis (R01) (PA-07-067)
Research Project Grant (Parent R01) (PA-07-070)
Molecular Genetics of Drug Addiction and Related Co-Morbidities (R01) (PA-07-073)
Research on the Reduction and Prevention of Suicidality (R01) (PA-07-079)
Women's Mental Health in Pregnancy and the Postpartum Period (R01) (PA-07-081)
Risk Factors for Psychopathology Using Existing Data Sets (R01) (PA-07-082)
Basic and Translational Research in Emotion (R01) (PA-07-083)
Developmental Psychopharmacology (R01) (PA-07-084)
Recent HIV Infection: New Prevention Challenges and Opportunities (R01) (PA-07-087)
Functional Links Between the Immune System, Brain Function and Behavior (R01)
(PA-07-088)
HIV Infection of the Central Nervous System (R01) (PA-07-089)
Drug Discovery for Nervous System Disorders (R01) (PA-07-048)
Drug Discovery for Nervous System Disorders (R21) (PA-07-049)
Dissemination and Implementation Research in Health (R01) (PA-07-086)
Senior Scientist Research and Mentorship Award (K05) (PA-06-555)
Women's Interagency HIV Study (WIHS) IV, Limited Competition (U01) (RFA-AI-07-004)
Neuroimaging Informatics Software Enhancement for Improved Interoperability and Dissemination (R03) (RFA-EB-07-002)
The Genes, Environment and Development Initiative (U01) (RFA-DA-07-012)
Joint NIDA-NIJ Initiative for Research on Retail Drug Markets (R21) (RFA-DA-07-013)
Ruth L. Kirschstein National Research Service Awards for Interdisciplinary Individual Postdoctoral Fellows for Training in Neurodegeneration Research (F32) (RFA-AG-07-004)
Short-term Interdisciplinary Career Enhancement Awards for Neurodegeneration Research (K18) (RFA-DC-07-005)
Therapeutics Delivery for Neurodegenerative Diseases (R21) (RFA-EY-07-001)
Biomarkers for Neurodegeneration (R21) (RFA-NS-07-004)
In November 2006, NIDA and the Dutch Addiction Program (DAP) announced the availability of administrative supplements in FY07 to support binational collaborative research projects. This program is a continuation of the U.S.-Netherlands Collaborative Research Program on Drug Abuse, using the uniquely successful model of joint funding for binational collaborative research. The joint scientific reviews conducted by the separate U.S. and Dutch funding agencies ensure that each binational research project meets the individual nations' research criteria and priorities; the joint funding permits NIDA and DAP to expand the impact of their scarce financial resources. NIDA provides support to the U.S. researcher and DAP provides support to the Dutch scientist. Letters of intent were due December 15, 2006; applications are due March 26, 2007; and funding will be approved no later than July 2007. The supplement announcement is available at: http://grants.nih.gov/grants/guide/notice-files/NOT-DA-07-003.html.
Other Program Activities
CTN Update
The CCTN received proposals in response to an NIH SBIR Contract Solicitation for the following titles. A review meeting is planned for February or March.
Topic 088, Automation of the Development of Electronic Data Capture System for Clinical Trials Data Collection and Management
Topic 089, Development of Practical Training Materials for Evidence-Based Treatment
A total of 25 protocols have been initiated since 2001. A total of 7,451 participants enrolled in studies as of October 31, 2006. Of these studies, 16 have completed enrollment and locked the data; four completed enrollment and are in the follow-up phase; and five are currently enrolling. Two new protocols are in the development phase.
Primary outcome papers are published and dissemination materials have been developed with CSAT's ATTC on the following:
Protocol CTN 0001, Buprenorphine/Naloxone versus Clonidine for Inpatient Opiate Detoxification
Protocol CTN 0002, Buprenorphine/Naloxone versus Clonidine for Outpatient Opiate Detoxification
Protocol CTN 0005, MI (Motivational Interviewing) To Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse
Protocol CTN 0006, Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics
Protocol CTN 0007, Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics
Eleven other protocols have locked the data:
Protocol CTN 0003, Bup/Nx: Comparison of Two Taper Schedules
Protocol CTN 0004, MET (Motivational Enhancement Treatment) To Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse
Protocol CTN 0008, A Baseline for Investigating Diffusion of Innovation
Protocol CTN 0009, Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy in Substance Abuse Rehabilitation Programs
Protocol CTN 0011, A Feasibility Study of a Telephone Enhancement Procedure (TELE) to Improve Participation in Continuing Care Activities
Protocol CTN 0012, Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infection, and Sexually Transmitted Infections in Substance Abuse Treatment Programs
Protocol CTN 0016, Patient Feedback: A Performance Improvement Study in Outpatient Addiction Treatment
Protocol CTN 0017, (HIV and HCV Intervention in Drug Treatment Settings).
Protocol CTN 0018, (Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment)
Protocol CTN 0019, (Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment)
Protocol CTN 0021, (Motivational Enhancement Treatment to Improve Treatment Engagement and Outcome for Spanish-Speaking Individuals Seeking Treatment for Substance Abuse). This is the first Spanish-only protocol in the CTN.
Four protocols have ended new enrollment and are in either follow-up or data-lock phase:
Protocol CTN 0010, (Buprenorphine/Naloxone Facilitated Rehabilitation for Opioid Dependent Adolescents/Young Adults) began enrollment in July 2003. Recruitment ended in January 2006.
Protocol CTN 0013, (Motivational Enhancement Therapy to Improve Treatment Utilization and Outcome In Pregnant Substance Abusers) began enrollment in November 2003 and completed recruitment in May 2006 and follow-up in September 2006.
Protocol CTN 0015, (Women's Treatment for Trauma and Substance Use Disorder: A Randomized Clinical Trial) began in March 2004. The study reached its enrollment target in October 2005, and follow-up continues until early 2007.
Protocol CTN 0020, (Job Seekers Training for Substance Abusers). The protocol began enrollment in October 2004 and reached its enrollment target in February 2006. This study is also being conducted in a Navajo American Indian site, the Na'nizhoozhi Center, Inc. in Gallup, New Mexico, the first CTN study to be conducted there. Follow-up is complete at all sites as of December 2006.
Five protocols are currently enrolling:
Protocol CTN 0014, Brief Strategic Family Therapy for Adolescent Drug Abusers (BSFT), has been implemented at eight sites. The study has reached 96% enrollment. There currently are a total of 460 randomized participants.
Protocol CTN 0027, Starting Treatment with Agonist Replacement Therapies (START) is a randomized, open-label, multi-center study that was developed in collaboration with the Division of Pharmacotherapies & Medical Consequences of Drug Abuse (DPMCDA). Enrollment began in April 2006 and includes eight sites. Seven of the sites are actively recruiting. As of October 31, 2006, there were 107 randomized participants.
Protocol CTN 0028, Randomized Controlled Trial of Osmotic-Release Methylphenidate (OROS MPH) for Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents with Substance Use Disorders (SUD). Enrollment is now open at 10 sites. Thirty-six participants have been randomized.
Protocol CTN 0029, A Pilot Study of Osmotic-Release Methylphenidate (OROS MPH) in Initiating and Maintaining Abstinence in Smokers with Attention Deficit Hyperactivity Disorder (ADHD). This study is being carried out at six community treatment sites across five Nodes. There are a total of 116 randomized participants.
Protocol CTN 0030, Prescription Opioid Addiction Treatment Study (POATS) is a randomized 2-phase, open-label, multi-center study in outpatient treatment settings. Pre-screening began in May 2006. The study will be carried out in 11 sites. Forty-three participants have been randomized.
Two protocols are in the development phase:
Protocol CTN 0031, Twelve-Step Facilitation: Evaluation of an Intervention to Improve Substance Abuse Treatment Outcomes by Increasing 12-Step Involvement. This protocol has been presented to the DSMB/Protocol Review Board.
Protocol CTN 0032, HIV Rapid Testing. This protocol is in the early planning stages; the concept was recently approved by the CTN Steering Committee and NIDA and the investigators will begin to develop the protocol.
In addition to the primary CTN trials, there are currently 27 funded studies supported by independent grants that use CTN studies as a platform.
NIDA's New and Competing Continuation Grants Awarded Since September 2006
Anastasio, Noelle C. -- University of Texas Medical Branch Galveston
Role of NMDAR Regulation in Phencyclidine-Induced Neurotoxicity
Anderson, Karen G. -- West Virginia University
Effects of Abused Drugs and Genetics on Impulsive Choice
Ang, Rosalind L. -- Mount Sinai School of Medicine of New York University
Mechanisms of Hallucinogen Specific Neuronal Response
Angstman, Sarah E. -- University of Montana
Tobacco Use Among Alaska Native College Students
Anthony, James C. -- Michigan State University
NIDA Epidemiology Training Program: ICOHRTA
Atkinson, Nigel S. -- University of Texas Austin
Chromatin Remodeling as a Mechanism to Produce Drug Tolerance
Bai, Guang -- University of Maryland Baltimore Professional School
Epigenetic Developmental Effects of Paternal Cocaine Exposure
Baicy, Kate -- University of California Los Angeles
Methamphetamine Dependence and Emotion Regulation
Baldwin, Gayle C. -- University of California Los Angeles
In Vivo Modeling of Methamphetamine and HIV Interactions
Barbarich-Marsteller, Nicole C. -- Associated University-Brookhaven National Laboratory
Neurochemical and Behavioral Alterations in Reward
Barr, Gordon A. -- Hunter College
MIDARP at Hunter College
Belenko, Steven R. -- Treatment Research Institute, Inc. (TRI)
Implementing Evidence-Based Drug Treatment in Criminal Justice Settings
Berg, Karina M. -- Yeshiva University
Improving Measurement of Antiretroviral Adherence in Current and Former Drug User
Bhide, Pradeep G. -- Massachusetts General Hospital
Cocaine and Brain Development
Blackard, Jason T. -- University of Cincinnati
Extrahepatic Replication and Viral Evolution of HCV During HCV/HIV Co-Infection
Blanco, Carlos -- New York State Psychiatric Institute
Substance Abuse In US Hispanics: A National Study
Booth, Brenda M. -- University of Arkansas Medical Sciences Little Rock
The 2006 Addiction Health Services Research Conference
Bornovalova, Marina A. -- University of Maryland College Park Campus
Distress Tolerance Treatment For Inner-City Drug Users
Boyer, Edward W. -- University of Massachusetts Medical School Worcester
Opioids, Internet Pharmacies, Self-Treated Chronic Pain, and HIV/AIDS
Brenner, Sharon L. -- University of Washington
Temperamental and Social Risk For Youth Substance Use
Brisson, Anne E. -- Columbia University Health Sciences
HIV Prevention With Heroin Using Women Sex Workers In Tajikistan
Brody, Gene H. -- University of Georgia
Preventing Substance Use and Risky Behavior Among Rural African American Youth
Bromberg, Jonas -- Inflexxion, Inc.
Improving Pain Management In Cancer Care In Latinos
Brookmeyer, Kathryn A. -- Georgia State University
Disentangling Pathways of Adolescent Sexual Risk from Problem Behavior Syndrome
Brown, Lawrence S. -- Addiction Research and Treatment Corp.
Electronic Information System To Enhance Practice At An Opioid Treatment Program
Brown, Russell W. -- East Tennessee State University
Amphetamine Sensitization In a Model of Schizophrenia
Burdon, William M. -- University of California Los Angeles
Residential Vs. Intensive Outpatient Prison-Based Treatment
Burdzovic Andreas, Jasmina -- Harvard University Medical School
Substance Use In Adolescents from High-Risk Neighborhoods: Risk and Protection
Cain, Mary E. -- Kansas State University
The Amygdala, Individual Differences, and Conditioned Hyperactivity
Caron, Marc G. -- Duke University
Drug Abuse: Discovering Ligands for Pertinent Gpcrs
Carroll, Kathleen M. -- Yale University
Computer-Based Training in Cognitve Behavioral Therapy
Carroll, Marilyn E. -- University of Minnesota Twin Cities
Vulnerability to Drug Abuse and Treatment Efficacy: Animal Models
Catalano, Richard F. -- University of Washington
Reducing Risk & Enhancing Protective Factors In Children
Chandra, Siddharth -- University of Pittsburgh at Pittsburgh
Population-Level Analyses of Multi-Drug Comsumption
Chao, Michael Y. -- California State University San Bernardino
Serotonin and Dopamine Regulation of Behavioral Plasticity In C. Elegans
Chartoff, Elena H. -- McLean Hospital, Belmont, MA
Consequences of Repeated Kappa Receptor Activation on Brain Stimulation Reward
Chavkin, Charles -- University of Washington
Dynorphins and Kappa Opioid Receptors in the Stress Response
Chen, Xiangning -- Virginia Commonwealth University
Genetics of Nicotine and Other Abused Substances
Cherek, Don R. -- University of Texas Health Sciences Center Houston
Drugs of Abuse and Human Aggressive Behavior
Chung, Hwan -- Michigan State University
Model Assessment and Selection for Latent Transition Models
Cochran, Susan D. -- University of California Los Angeles
Drug Use, HIV, and Other Comorbidities In A Vulnerable Population
Cohen, Mark S. -- University of California Los Angeles
Comprehensive Training In Neuroimaging Fundamentals and Applications
Cohen, Mark S. -- University of California Los Angeles
Comprehensive Training in Neuroimaging Fundamentals and Applications
Colder, Craig R. -- State University of New York at Buffalo
Problem Behavior, Peers, and Motivational Aspects of Temperament In Substance Use
Coles, Lisa D. -- University of Maryland Baltimore Professional School
Changes in Brain and Placental Distribution During Pregnancy
Colfax, Grant N. -- Public Health Foundation Enterprises
Aripiprazole Treatment for Methamphetamine Dependence among High-Risk MSM
Comer, Sandra D. -- New York State Psychiatric Institute
Sustained-Release Naltrexone for Opioid Dependence: Longitudinal Study In Humans
Conrad, Kelly L. -- Rosalind Franklin University of Medicine & Science
Cocaine Craving and Receptor Trafficking
Copenhaver, Michael M. -- University of Connecticut Storrs
A Healthy Transition for Newly Released HIV-Infected Prisoners
Copenhaver, Michael M. -- University of Connecticut Storrs
Testing A Community-Friendly Risk Reduction Intervention For Injection Drug Users
Cottler, Linda B. -- Washington University
Indo-US Fogarty Training Program In Behavioral Disorders
Cottler, Linda B. -- Washington University
Prescription Drug Misuse, Abuse and Dependence
Courser, Matthew -- Pacific Institute for Research and Evaluation
The Impact of Active Consent On Student Survey Data
Coviello, Donna M. -- University of Pennsylvania
Employment Intervention For Offenders
Crowley, Thomas J. -- University of Colorado Denver/Health Science Center Aurora
Substance Dependent Adolescents: Imaging Risk-Taking
Damaj, Mohamad Imad -- Virginia Commonwealth University
Role of Calcium-Dependent Mechanisms In Nicotine's Tolerance and Effects
D'aquila, Richard T. -- Vanderbilt University
Vanderbilt Meharry Center for AIDS Research
Dawidowicz, Eliezar A. -- Marine Biological Laboratory
Neural Development and Genetics of Zebrafish
Day, Jeremy J. -- University of North Carolina Chapel Hill
Neural Regulation of Effort In Goal-Directed Behaviors
De Lecea, Luis -- Stanford University
Hypocretin and Drug Addiction
Delbello, Melissa P. -- University of Cincinnati
Topiramate For Co-Occurring Cannabis Use and Bipolar Disorders In Adolescents
Dembo, Richard -- University of South Florida
Brief Intervention for Drug Use and HIV/STD Risk Prevention Among Non-Delinquent Truants
Dewey, William L. -- Virginia Commonwealth University
Training In the Pharmacology of Abused Drugs
Dichter, Marc A. -- University of Pennsylvania
Postdoc Training In Translational Research In Neural Injury and Neurodegeneration
Dickinson, Michael H. -- California Institute of Technology
Crcns: Automated Behavior Analysis for Model Genetic Organism
Dickson-Gomez, Julia B. -- Institute for Community Research
High Risk Crack Use Settings and HIV In El Salvador
Domino, Edward F. -- University of Michigan at Ann Arbor
Effects of Nicotine On Human Cerebral Transmitters
Dracheva, Stella -- Mount Sinai School of Medicine of New York University
Vulnerability to Addiction: A Role For 5-Ht2c Receptor Editing and Expression
Drenan, Ryan M. -- California Institute of Technology
Nicotinic ACh Receptors and Noradrenergic Neurotransmission In Nicotine Addiction
Eby, Lillian T. -- University of Georgia
Clinical Supervision and Turnover In Substance Abuse Treatment
Edwards, Robert H. -- University of California San Francisco
Presynaptic Mechanisms of Neural Plasticity
Eitan, Shoshana -- Texas A&M University System
Functionality of the Opioid System During Adolescent Development Across Genders
Eliassen, James C. -- University of Cincinnati
Linking Serotonin and Memory Functions In MDMA Users By Concurrent EEG and fMRI
Elmer, Gregory I. -- University of Maryland Baltimore Professional School
Algorithm for Drug Discovery
Engle, Bretton C. -- Florida International University
Commitment Language In Adolescent AOD Treatment Groups
Eshleman, Susan H. -- Johns Hopkins University
HIV Prevention Trials Network: Network Laboratory
Evins, A. Eden -- Massachusetts General Hospital
Glycine Transport Inhibition for Nicotine Dependence In Schizophrenia
Fellows, Lesley K. -- McGill University
Orbitofrontal and Striatal Mechanisms In Stress and Addiction
Finkel, Leif H. -- University of Pennsylvania
Integrated Interdisciplinary Training In Computational Neuroscience
Fleming, Thomas R. -- Fred Hutchinson Cancer Research Center
Leadership for HIV/AIDS Clinical Trials Networks: HIV Prevention Trials Network
Fortuna, Lisa R. -- Cambridge Health Alliance
CBT Treatment For PTSD and SUDs In Minority Youth
Fricker, Lloyd D. -- Yeshiva University
Neuropeptides, Processing Enzymes, and Drug Abuse
Furneaux, Henry M. -- University of Connecticut School of Medicine and Dentistry
Cannabinoid Receptor (CNR1) MicroRNAs and Addictive Disease
Garavan, Hugh P. -- Nathan S. Kline Institute for Psychiatric Research
The Role of Executive Functions In Cocaine Abuse
Garris, Paul A. -- Illinois State University
Mechanisms of Amphetamine Action On Dopaminergic Signaling
Glenzer, Vicky Ann -- Oregon Center for Applied Science, Inc.
Interactive Training for Parents of At-Risk Children
Glenzer, Vicky Ann -- Oregon Center for Applied Science, Inc.
Internet Step-parent Training For Parents of Adolescents
Goldowitz, Daniel -- University of Tennessee Health Science Center
Gene To Phenotype Networks For Alcohol & Drug Addiction
Gorbach, Sherwood L. -- Tufts University Boston
HIV Infection In Drug Users In Two International Sites
Graham, Amanda L. -- Society of Behavioral Medicine
Society of Behavioral Medicine Annual Meeting & Scientific Sessions
Greenwald, Mark K. -- Wayne State University
Reducing Cocaine/Heroin Abuse With SR-Amphetamine and Buprenorphine
Grodzicker, Terri I. -- Cold Spring Harbor Laboratory
CSHL Conference On Channels, Receptors, Synapses
Gu, Howard H. -- Ohio State University
Cocaine and Monoamine Transporters
Gustafson, David H. -- University of Wisconsin Madison
RCT Evaluating Improvement Strategies for Addiction Treatment
Hall, Edward D. -- University of Kentucky
Therapeutic Strategies for Neurodegeneration Training Grant
Harris, Kathleen Mullan -- University of North Carolina Chapel Hill
The National Longitudinal Study of Adolescent Health
Hawrot, Edward -- Brown University
Role of Alpha3-Containing Nicotinic Receptors In Mediating Central Nicotine Effects
Hawrot, Edward -- Brown University
The Neuronal Nicotinic Acetylcholine Receptor Interactome Via A Knock-In Mouse
He, Johnny J. -- Indiana University-Purdue University at Indianapolis
Use A Novel Tat Transgenic Model To Develop Neuroaids Therapeutics
Heatherton, Todd F. -- Dartmouth College
Effects of Social Context On The Neural Correlates of Cue Reactivity
Henggeler, Scott W. -- Medical University of South Carolina
Vocational Outcomes For Youth With Substance Abuse Problems and High HIV Risk
Heninger, George R. -- Yale University
Substance Abuse Education for Medical Students
Hinds, Bruce J. -- University of Kentucky
Gated Carbon Nanotube Membrane Transdermal Drug Delivery
Hogle, Joanne M. -- University of Wisconsin Madison
Sex Differences In the Effect of Smoking Withdrawal on Emotion Response
Hohmann, Andrea G. -- University of Georgia
Endocannabinoid Analgesia: An In Vivo Gene Transfer - Lipidomics Approach
Hoshino, Yoshihiko -- New York University School of Medicine
RNAS Editing and Its Inhibition Of HIV-1 Replication In Human Macrophage
Howe, Chanelle J. -- Johns Hopkins University
Methods For Informative Censoring HIV/AIDS Cohorts
Howell, Leonard L. -- Emory University
PET Imaging and Cocaine Neuropharmacology In Monkeys
Huang, Yiyun -- Yale University
New PET Radioligand For the Serotonin Transporter
Hubert, George W. -- Emory University
Anatomy and Activation of Nucleus Accumbens CART Neurons
Hurt, Richard D. -- Mayo Clinic College of Medicine, Rochester
Efficacy of Methylphenidate For Treating Tobacco Dependence
Inciardi, James A. -- University of Delaware
Case Management Alternatives for African American Women At High Risk For HIV
Jackson-Newsom, Julia -- Tanglewood Research, Inc.
Drug Prevention for Children In After-School and Community Settings
Jacobs, Russell E. -- California Institute of Technology
In Vivo Detection of Neuronal Activity
Janowsky, Aaron J. -- Oregon Health & Science University
Methamphetamine Abuse Research Center
Jarcho, Johanna M. -- University of California Los Angeles
Dopamine's Role In Pain Sensivity & Placebo Analgesia
Kadden, Ronald M. -- University of Connecticut School of Medicine and Dentistry
Contingency Management for Marijuana Dependence
Kaestner, Klaus H. -- University of Pennsylvania
Development of C57bl/6 Es Cell Technology For High Thoughput Use
Kass, Robert E. -- Carnegie-Mellon University
Interdisciplinary Training In Computational Neuroscience
Kessler, John A. -- Northwestern University
Training For A New Interdisciplinary Research Workforce In Regenerative Medicine
Kim, Seong-Gi -- University of Pittsburgh at Pittsburgh
Multimodal Neuroimaging Training Program
Kirby, Lynn G. -- Temple University
Regulation of Serotonin Circuits In Opiate Addiction and Relapse
Knackstedt, Lori A. -- Medical University of South Carolina
Evaluating Models of Cocaine Self-Administration
Knowlton, Amy R. -- Johns Hopkins University
Informal Caregiving & Medical Adherence Among HIV+ IDUs
Knuepfer, Mark M. -- Saint Louis University
Effects of Chronic Stress Or Psychostimulants On CNS and ANS
Koodie, Lisa -- University of Minnesota Twin Cities
Morphine Induced Modulation of Tumor Growth
Kosterman, Richard -- University of Washington
Social Development and Psychopathology Into Adulthood
Kral, Alexander H. -- Research Triangle Institute
Correlates of Sexual Risk For HIV/STI Among Women Who Use Methamphetamine
Kushel, Margot B. -- University of California San Francisco
Pain and Misuse of Prescription Opioids In A Community-Based HIV-Infected Cohort
Labrie, Richard A. -- Cambridge Health Alliance
An Assessment of A Problem Gambling Self-Change Toolkit
Lahvis, Garet P. -- University of Wisconsin Madison
Social Approach Behaviors and Reward Pathways of Adolescent Mice
Lau, Elaine K. -- University of California San Francisco
Morphine-Regulated Phosphorylation of Opioid Receptors
Lee, Yue-Wei (David) -- McLean Hospital, Belmont, MA
Pharmacology and Metabolism Of Salvia Divinorum
Lee, Yun J. -- Women and Infants Hospital-Rhode Island
Massage for Methadone Exposed Infants
Levin, Frances R. -- New York State Psychiatric Institute
Combined Pharmacotherapies for Cocaine Dependence
Li, Chiang-Shan R. -- Yale University
Imaging Inhibitory Control In Cocaine Dependence
Liao, Dezhi -- University of Minnesota Twin Cities
Opioid Receptors In Excitatory Synapses
Lillie-Blanton, Marsha D. -- George Washington University
HIV/AIDS & Women of Color: Roles of Drug Use, Violence & Insurance In HAART Use
Lindsey, Kimberly P. -- McLean Hospital, Belmont, MA
Pharmacologic MRI of Smoked Tobacco: Effects of Abstinence and Dependence
Listman, Jennifer B. -- New York University
Population Genetics & Drug Dependence In Asian Isolates
Liu, Hongjie -- Wayne State University
A Pilot Study of School-Based HIV Intervention In China
Locey, Matthew L. -- University of Florida
Nicotine and the Behavioral Mechanisms of Impulsivity
London, Edythe D. -- University of California Los Angeles
Methamphetamine Abuse, Inhibitory Control: Implications for Treatment
Low, Walter C. -- University of Minnesota Twin Cities
Translational Research In Neurobiology of Disease Training Program
Lute, Brandon J. -- Vanderbilt University
Amphetamine Regulation of the Dopamine Transporter
Mahler, Stephen V. -- University of Michigan at Ann Arbor
Opioid Modulation of Cue-Triggered 'Wanting' In Amygdala
Malison, Robert T. -- Yale University
Genetics of Opioid Dependence In A Hmong (Thai) Isolate
Malow, Robert M. -- Florida International University
Multi-Level HIV Prevention for Pregnant Drug Abusers
Mao, Jianren -- Massachusetts General Hospital
Opioid-Induced Pain Sensitivity: Clinical Diagnosis and Management
Marcus, Bess H. -- Miriam Hospital
Using A YMCA Exercise Program To Enhance Nicotine Dependence Treatment For Women
Margiotta, Joseph F. -- Medical University of Ohio at Toledo
Altering Gene Expression and Function At Single Neuronal Nicotinic Synapses
Marians, Kenneth J. -- Sloan-Kettering Institute for Cancer Research
Integrated PhD Training Program In Cancer Biology
Marinelli, Michela -- Rosalind Franklin University of Medicine & Science
Adolescent Cocaine Abuse: Electrophysiology & Behavior
Marnett, Lawrence J. -- Vanderbilt University
Integrative Training In Therapeutic Discovery
Marota, John J. -- Massachusetts General Hospital
Effects of Cocaine Self-Administration: fMRI of Awake Non-Human Primates
Marsch, Lisa A. -- National Development & Research Institutes
Computer-Delivery of Effective, Psychosocial Interventions In Methadone Treatment
Martin, Thomas J. -- Wake Forest University Health Sciences
Role of the Amygdala In Opioid Self-Administration In Rats With Chronic Pain
Martinez, Charles R. -- Oregon Social Learning Center, Inc.
A Culturally Specific Intervention for Latino Families
Marzluff, William F. -- University of North Carolina Chapel Hill
UNC-Chapel Hill Integrated Biomedical Research Training Program
Masson, Carmen L. -- University of California San Francisco
Hepatitis Care Coordination In Methadone Treatment
Mathew, Rano T. -- Coastal Horizons Center, Inc.
Improving Co-Occurring Disorder Care in Rural Areas Via Technology Enhancements
May, James C. -- Richmond Behavioral Health Authority
Organizational Factors Influencing Practice Improvement In Community-Based Care
Mayford, Mark R. -- Scripps Research Institute
CBP Acetyltransferase Function In Addictive Behavior
Mcginn, Thomas G. -- Mount Sinai School of Medicine of New York University
Prevention of Depression In HIV/HCV Co-Infected Substance Abuse Patients
Mcginnis, Marilyn Y. -- University of Texas San Antonio
Anabolic Androgenic Steroid Effects on Brain and Behavior
Mckay, James R. -- University of Pennsylvania
Effectiveness of Extended Treatments for Drug Dependence
Mcmanus, Michael T. -- University of California San Francisco
The Epigenetics of Small RNAs In the Mammalian Brain
Muehlbach, Britta -- Daytop Village
Technology Transfer: Promoting Change In The Therapeutic Community
Nagy, Andras -- Mt. Sinai Hospital-Samuel Lunenfeld Research Institute
Contribution to the Completion of Comprehensive Mouse Knockout Resource
Nair, Madhavan P. -- State University of New York at Buffalo
Immunopathogenesis of HIV-1 Infection: Role of Methamphetamine
Naleid, Amy M. -- University of Washington
VTA Opioid, GABA, and Insulin Effects on Sucrose Reward
Nelson, Christopher L. -- Rosalind Franklin University of Medicine & Science
Cellular Plasticity Following Repeated Amphetamine
Nemes, Susanna -- Social Solutions International
Buprenorphine
Nielsen, David A. -- Rockefeller University
DNA Methylation of Promoter CPG Dinucleotides In Opiate Addiction
Nunes, Edward V. -- New York State Psychiatric Institute
Opiate Dependence: Combined Naltrexone/Behavior Therapy
Ochsner, Kevin N. -- Columbia University New York Morningside
The Neural Bases of Affect Regulation in Drug Abuse
Oliveto Beaudoin, Alison -- University of Arkansas Medical Sciences Little Rock
Disulfiram for Cocaine Abuse In Methadone Patients
Ossipov, Michael H. -- University of Arizona
Proteasome Inhibitors: Therapeutics for Pain
Ouellet, Lawrence J. -- University of Illinois at Chicago
Psychiatric Disorders and HIV Risk Behaviors Among Young Injection Drug Users
Palmer, Abraham A. -- University of Chicago
Mouse QTL and Human Association Study of Methamphetamine Sensitivity
Palzkill, Timothy G. -- Baylor College of Medicine
Training In Biomedical Discovery from Large Scale Data Sets
Pantin, Debra Cherry-Ann -- Palladia, Inc.
Developing A CQI Intervention To Implement EBP Within A CBO
Patterson, Thomas L. -- University of California San Diego
Behavior Change and Maintenance Intervention for HIV+ MSM Methamphetamine Users
Paul, Robert H. -- University of Missouri-St. Louis
Functional Neuroimaging of Cognitive Dysfunction In HIV-HCV Co-Infection
Paulson, Autumn M. -- University of Maryland College Park Campus
Anxiety Vulnerabilities In Heroin Users
Pauly, James R. -- University of Kentucky
Prenatal Nicotine, Behavioral Teratogenicity and Dopamine
Pearlson, Godfrey D. -- Yale University
Reward, Impulsivity and Cocaine Addiction: fMRI Studies
Pearson, Zsuzsanna S. -- New York University School of Medicine
Modulation of Dopamine Release By CB1 Receptors
Perkins, Kenneth A. -- University of Pittsburgh at Pittsburgh
Tobacco Smoking, Nicotine and Negative Affect Relief
Perlman, David C. -- Beth Israel Medical Center, New York
Hepatitis Care Coordination In Methadone Treatment
Perron, Brian E. -- Washington University
Psychiatric Comorbidities and Outpatient Substance Abuse Treatment Retention
Perry, Jennifer L. -- University of Minnesota Twin Cities
Impulsivity and Drug Abuse: Sex and Hormonal Effects
Pinto, Elsa -- Florida International University
Dietary Patterns and Drug Use Among Latinas
Piomelli, Daniele -- University of California Irvine
Role of Endocannabinoids In the Behavioral Consequences of Social Isolation
Plant, Tony M. -- University of Pittsburgh at Pittsburgh
International Congress of Neuroendocrinology (ICN 2006)
Pouget, Alexandre -- University of Rochester
CRCNs: Bayesian Decision Making With Probabilistic Population Codes
Quintero, Gilbert A. -- University of New Mexico Albuquerque
Prescription Drug Abuse: The Role of the Internet
Raehal, Kirsten M. -- Ohio State University
Opioid-Induced Somatic Effects In Betaarrestin2-Ko Mice
Ramo, Danielle E. -- University of California San Diego
Developmental Models of Drug Abuse Relapse
Reith, Maarten E. -- New York University School of Medicine
The Dopamine Transporter and Ions, Substrates, Blockers
Reith, Maarten E. -- New York University School of Medicine
Dopamine Transporters: Mechanisms of Ligand Interaction
Reynolds, Jessica L. -- State University of New York at Buffalo
Mechanisms of Cocaine-Induced HIV-1 Infection In NHA
Rigotti, Nancy A. -- Massachusetts General Hospital
Bupropion for Smoking Cessation In Postpartum Women
Roe, Anna W. -- Vanderbilt University
Fast Optical Imaging of Cortical Signals In the Behaving Primate
Roget, Nancy A. -- University of Nevada Reno
NIDA Enters College: Infusing The Science of Addiction Into University Curricula
Rogge, George A. -- Emory University
Regulation of The CART Gene By Promoter CIS-Elements
Rosen, Bruce R. -- Massachusetts General Hospital
Advanced Multimodal Neuroimaging Training Grant
Rosenblum, Andrew Bruce -- National Development & Research Institutes
Sublingual Buprenorphine for Chronic Pain In Patients at Risk for Drug Abuse
Rosengard, Cynthia -- Rhode Island Hospital, Providence, RI
Partner-Specific HIV Risk Reduction for Drug Using Incarcerated Adolescents
Roth, Michael D. -- University of California Los Angeles
Effects of Marijuana on HIV and Viral Immunity
Rowland, Neil E. -- University of Florida
Cue Dependency With Intravenous Nutrients and Nicotine
Royal, Walter -- University of Maryland Baltimore Professional School
Opoid and Retinoid Interactions In the HIV-1 Transgenic Rat
Sadee, Wolfgang -- Ohio State University
Genetic and Epigenetic Regulation of Addiction Genes
Salom, David -- Novasite Pharmaceuticals, Inc.
Crystallization of the Human Cannabinoid Type 2 Receptor
Samet, Jeffrey H. -- Boston Medical Center
Clinical Addiction Research and Education (CARE) Program
Schacht, Joseph P. -- University of Colorado at Boulder
A Transdisciplinary Approach to Cannabis Addiction
Schank, Jesse R. -- Emory University
Dopamine Beta-Hydroxylase and Responses to Cocaine
Schramm-Sapyta, Nicole L. -- Duke University
Role of HPA Axis In Adolescent Vulnerability to Drug Addiction
Schwartz, Philip H. -- Children's Hospital of Orange County
Choc Human Embryonic Stem Cell Culture Training Course
Scott, David J. -- University of Michigan at Ann Arbor
Brain Reward Circuitry and Substance Use Risk
See, Ronald E. -- Medical University of South Carolina
Translational Research in Addiction Center
Shiffman, Saul -- University of Pittsburgh at Pittsburgh
Understanding Emerging Patterns of Non-Daily Smoking: Field and Lab Assessments
Simen, Arthur A. -- Yale University
Epigenetic Factors In Stress-Enhanced Acquisition of Cocaine Self-Administration.
Slesnick, Natasha -- Ohio State University
Evaluation of Treatments For Homeless Youth: CRA, MET and Case Management
Snedker, Karen A. -- University of Washington
The Impact of Neighborhood Context on Substance Abuse
Sofuoglu, Mehmet -- Yale University
GABA Medications for Tobacco Addiction
Sokhadze, Estate M. -- University of Louisville
Emotional and Attentional Biases to Drug and Trauma Cues In Addiction With PTSD
Sombers, Leslie A. -- University of North Carolina Chapel Hill
Functional Analysis of the Mesolimbic Dopamine System
Sood, Amit -- Mayo Clinic College of Medicine, Rochester
Gabapentin for Smoking Abstinence
Sorensen, James L. -- University of California San Francisco
Daart+ As A Structural HIV Intervention In Methadone Maintenance
Sorg, Barbara A. -- Washington State University
Cocaine, Electroconvulsive Seizure and Neural Plasticity
Spiess, Joachim -- University of Hawaii at Manoa
Emotion and Cognition On Gene, Cell, and Systems Levels
Stahl, Philip D. -- Washington University
21st-Century Imaging Sciences: Undergraduate and Graduate Student Training
Stefansson, Kari -- Decode Genetics, Inc.
Genes Contributing To Opioid Abuse In Humans
Stein, Michael D. -- Rhode Island Hospital, Providence, RI
Antidepressants During Office-Based Buprenorphine
Steinberg, Laurence -- Temple University
Peer Effects on Neural and Behavioral Markers of Risk-Taking
Stella, Nephi -- University of Washington
Novel Monoacylglycerol Lipase
Stenger, Victor A. -- University of Hawaii at Manoa
Parallel MRI for Substance Abuse Research
Stone, Laura S. -- University of Minnesota Twin Cities
Proteomic Studies of Human Chronic Pain
Strain, Eric C. -- Johns Hopkins University
Evaluation of Opioid Antagonist Activity In Humans
Sullivan, Mark D. -- University of Washington
Risks for Opioid Use and Abuse In Contrasting Chronic Pain Populations
Sun, Yi E. -- University of California Los Angeles
Epigenetic Gene Regulation In Morphin Addiction
Swanstrom, Ronald I. -- University of North Carolina Chapel Hill
UNC Center For AIDS Research
Szczytkowski-Thomson, Jennifer -- University of North Carolina Chapel Hill
Conditioned Effects of Heroin on Nitric Oxide
Tank, Arnold W. -- University of Rochester
Nicotine Effects on the Adrenal Medulla and Brain
Tank, David W. -- Princeton University
Training Program In Quantitative and Computational Neuroscience
Teplin, Linda A. -- Northwestern University
Drug Use, Disorder & HIV/AIDS Risk In Juvenile Justice Youth:A Longitudinal Study
Thompson, Alexis C. -- State University of New York at Buffalo
Evaluation of Neuropeptide Y As A Target for Cocaine-Dependence Treatment
Todorov, Alexandre A. -- Washington University
Genetic Epidemiology of Opioid Dependence In Bulgaria
Tranel, Daniel T. -- University of Iowa
Drug Abuse, Social Decision-Making, and Sex-Related Functional Brain Asymmetry
Troncale, Joseph A. -- Caron Foundation
Integrated Behavioral Program For Prescription Opiate Addiction and Chronic Pain
Tucker, Jalie A. -- University of Alabama at Birmingham
Telehealth Assessment of Risk Behaviors In Rural HIV+ Substance Users
Ulinski, Philip S. -- University of Chicago
Undergraduate Training In Computational Neuroscience
Umbricht, Annie -- Johns Hopkins University
Clinical Trial of Topiramate For Cocaine Addiction
Uteshev-Gaard, Victor V. -- Southern Illinois University Carbondale
Studying Nicotinic AChrs In Histaminergic Neurons
Valenzuela, David M. -- Regeneron Pharmaceuticals, Inc.
Production of Targeted Null Mutations For 10,000 Genes In C57bl/6 Es Cells
Vermund, Sten H. -- Family Health International
HIV Prevention Trials Network (HPTN) Coordinating and Operations Center
Volsky, David J. -- St. Luke's-Roosevelt Institute for Health Sciences
Effect of Morphine on HIV-1 Neuroinvasion and Brain Changes In Mice
Von Korff, Michael R. -- Center for Health Studies
Long-Term Opioid Management of Chronic Pain: Trends and Risks
Von Zastrow, Mark E. -- University of California San Francisco
Mechanisms Regulating Endocytosis of Opioid Receptors
Walsh, Sharon L. -- University of Kentucky
Evaluation of Atomoxetine for Cocaine Dependence: A Pilot Trial
Wang, Shaomeng -- University of Michigan at Ann Arbor
Design, Synthesis and Characterization Of Dopamine Receptor 3 Ligands
Watkins, Katherine E. -- Rand Corporation
Group CBT For Depression and AOD Disorders
Welch, Sandra P. -- Virginia Commonwealth University
Modulation of Opioid Antinociception and Tolerance By Sphingosine-1-Phosphate
Wells, Rebecca S. -- University of North Carolina Chapel Hill
How Child Welfare Inter-Agency Cooperation May Reduce Youth HIV Risk Behaviors
West, Anne Elizabeth -- Duke University
Epigenetic Regulation of Transcriptional Repression By Drugs of Abuse
West, Mark O. -- Rutgers, The State University of New Jersey, New Brunswick
Cue-Induced Relapse to Cocaine Seeking: Neuronal Activity In Accumbens Circuits
Westmaas, Johann L. -- State University New York Stony Brook
Gender, Social Support, and Stress Reactions In Smokers
Wilens, Timothy E. -- Massachusetts General Hospital
Juvenile Bipolar Disorder and Substance Abuse
Williams, Jason M. -- Vanderbilt University
Insulin Regulation of Amphetamine Action
Wirtshafter, David -- University of Illinois at Chicago
Lateral Hypothalamus, Dopamine and Ingestive Behavior
Wong, Dean F. -- Johns Hopkins University
Training for Clinician Scientists In Imaging Research
Woody, George E. -- University of Pennsylvania
Methadone Maintenance and HIV Risk In Ukraine
Wu, Z. Helen -- University of Texas Medical Branch Galveston
Does Stress Influence Drug Use In Young, Poor Women?
Xu, Jiansong -- University of California Los Angeles
Cigarette Smoking and the Efficiency of the Frontoparietal Attentional Network
Yoburn, Byron C. -- St. John's University
Prescription Opioid Agonists: Tolerance and Efficacy
Zhan, Chang-Guo -- University of Kentucky
Redesign of Butyrylcholinesterase for Cocaine Metabolism
Zhuang, Xiaoxi -- University of Chicago
Epigenetic Mechanisms In Motor Habits Stability
Zubieta, Jon-Kar -- University of Michigan at Ann Arbor
Neurochemistry of Opiate Abuse Risk In Chronic Pain
Zucker, Robert A. -- University of Michigan at Ann Arbor
International Substance Abuse Research Training Program
|
